Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC22086847;6848;6849 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814
N2AB22086847;6848;6849 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814
N2A22086847;6848;6849 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814
N2B21626709;6710;6711 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814
Novex-121626709;6710;6711 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814
Novex-221626709;6710;6711 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814
Novex-322086847;6848;6849 chr2:178775089;178775088;178775087chr2:179639816;179639815;179639814

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAT
  • RefSeq wild type template codon: ATA
  • Domain: Ig-11
  • Domain position: 35
  • Structural Position: 49
  • Q(SASA): 0.1561
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/C rs1186847832 None 0.822 N 0.55 0.145 0.346768085243 gnomAD-3.1.2 6.57E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
Y/C rs1186847832 None 0.822 N 0.55 0.145 0.346768085243 gnomAD-4.0.0 5.07445E-06 None None None None N None 0 0 None 0 0 None 0 0 6.02446E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.5313 ambiguous 0.551 ambiguous -2.549 Highly Destabilizing 0.104 N 0.461 neutral None None None None N
Y/C 0.1227 likely_benign 0.1222 benign -1.149 Destabilizing 0.822 D 0.55 neutral N 0.448786745 None None N
Y/D 0.4914 ambiguous 0.5245 ambiguous -1.138 Destabilizing 0.822 D 0.607 neutral N 0.3912295 None None N
Y/E 0.5546 ambiguous 0.5752 pathogenic -1.037 Destabilizing 0.364 N 0.551 neutral None None None None N
Y/F 0.0551 likely_benign 0.053 benign -1.09 Destabilizing None N 0.207 neutral N 0.348086369 None None N
Y/G 0.5377 ambiguous 0.5575 ambiguous -2.878 Highly Destabilizing 0.364 N 0.563 neutral None None None None N
Y/H 0.1285 likely_benign 0.132 benign -1.18 Destabilizing 0.822 D 0.497 neutral N 0.318984817 None None N
Y/I 0.2834 likely_benign 0.2834 benign -1.537 Destabilizing 0.055 N 0.421 neutral None None None None N
Y/K 0.4172 ambiguous 0.4335 ambiguous -1.229 Destabilizing 0.364 N 0.523 neutral None None None None N
Y/L 0.2483 likely_benign 0.2548 benign -1.537 Destabilizing None N 0.282 neutral None None None None N
Y/M 0.3325 likely_benign 0.3303 benign -1.198 Destabilizing 0.011 N 0.332 neutral None None None None N
Y/N 0.1994 likely_benign 0.2104 benign -1.513 Destabilizing 0.822 D 0.595 neutral N 0.448552247 None None N
Y/P 0.9881 likely_pathogenic 0.9887 pathogenic -1.873 Destabilizing 0.859 D 0.599 neutral None None None None N
Y/Q 0.3172 likely_benign 0.3348 benign -1.479 Destabilizing 0.667 D 0.546 neutral None None None None N
Y/R 0.2915 likely_benign 0.3115 benign -0.733 Destabilizing 0.667 D 0.596 neutral None None None None N
Y/S 0.2573 likely_benign 0.276 benign -2.124 Highly Destabilizing 0.301 N 0.507 neutral N 0.347057496 None None N
Y/T 0.4036 ambiguous 0.4152 ambiguous -1.928 Destabilizing 0.364 N 0.511 neutral None None None None N
Y/V 0.2611 likely_benign 0.2623 benign -1.873 Destabilizing 0.025 N 0.371 neutral None None None None N
Y/W 0.316 likely_benign 0.327 benign -0.551 Destabilizing 0.667 D 0.515 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.